Mankind Pharma Ltd (MANKIND) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003845, "name": "Mankind Pharma", "stock_name": "Mankind Pharma", "full_name": "Mankind Pharma Ltd", "name_url": "stocks-analysis/mankind-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "2,439.00", "chg": 8.1, "chgp": "0.33%", "dir": 1, "prev_price": "2,430.90", "mcapval": "100,358.00 Cr", "mcap": "Mid Cap", "scripcode": 543904, "symbol": "MANKIND", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE634S01028", "curr_date": "Aug 07, 03:30 PM", "curr_time": "23:50 PM", "last_traded_at": "Aug 07, 03:30 PM IST", "bse_nse_vol": "1.77 lacs", "exc_status": "Active", "traded_date": "Aug 07, 2026", "traded_date_str": "2026 08 07", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mankind-pharma-1003845-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Mankind Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-4135423", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MankindPharmaLt_technicaldot_4135423.png", "date": "2026-08-04 08:10:39", "description": "Mankind Pharma Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early August 2026. Despite a modest day change of 0.18%, the stock’s technical indicators present a nuanced picture, with some signals pointing to strength while others suggest caution. This article analyses the recent technical parameter changes, key momentum indicators, and the stock’s performance relative to the broader market." }, { "title": "Mankind Pharma’s Volatile Week: -1.42% Price Drop Amid Surging Open Interest and Technical Shifts", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharmas-volatile-week--142-price-drop-amid-surging-open-interest-and-technical-shifts-4131347", "imagepath": "", "date": "2026-08-01 11:02:26", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> Stock rises 1.82% amid broad market gains</p>\n <p><strong>28 Jul:</strong> Sharp open interest surge of 14.5% despite Sensex dip</p>\n <p><strong>29 Jul:</strong> Open interest climbs 15.2%, Mojo Grade upgraded to Buy</p>\n <p><strong>30 Jul:</strong> Q1 FY27 results reveal strong revenue growth but margin pressures</p>\n <p><strong>31 Jul:</strong> Intraday low hit at Rs.2,445.45 amid heavy selling and 45.8% open interest surge</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat..." }, { "title": "Are Mankind Pharma Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-mankind-pharma-ltd-latest-results-good-or-bad-4130687", "imagepath": "", "date": "2026-07-31 19:22:27", "description": "Mankind Pharma Ltd's latest financial results for the quarter ended June 2026 present a complex picture characterized by strong revenue growth alongside margin pressures. The company reported net sales of ₹4,030.59 crores, reflecting a sequential increase of 17.07% from the previous quarter, which marks the highest quarterly revenue in its history. Year-on-year, sales also showed a healthy growth of 12.89%, indicating robust demand across its product portfolio and effective market strategies.\n\nHowever, the net profit for the same quarter was ₹568.06 crores, which represents a modest sequential growth of 2.47%. This contrasts with the more substantial profit growth seen in the previous quarter. The operating margin decreased to 26.20%, down 81 basis points from the prior quarter, highlighting the impact of rising employee costs, which surged by 21.54% sequentially. This increase in employee expenses has rais..." }, { "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-volatile-trading-4130502", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_oi_spurts_by_underlying_4130502.png", "date": "2026-07-31 15:00:23", "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the pharmaceutical company’s futures and options contracts have attracted increased volumes, reflecting a complex interplay of directional bets and volatility." }, { "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-volatile-trading-4130452", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_oi_spurts_by_underlying_4130452.png", "date": "2026-07-31 14:00:17", "description": "Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market reveals intriguing directional bets that merit close attention from investors and analysts alike." }, { "title": "Mankind Pharma Ltd Sees Sharp Open Interest Surge Amid Volatile Trading", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-sees-sharp-open-interest-surge-amid-volatile-trading-4130397", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_oi_spurts_by_underlying_4130397.png", "date": "2026-07-31 13:00:14", "description": "Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market shows signs of increased speculative interest, raising questions about potential directional bets and future price movements." }, { "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-volatile-trading-4130354", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_oi_spurts_by_underlying_4130354.png", "date": "2026-07-31 12:00:14", "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the pharmaceutical company’s futures and options contracts have attracted increased volumes, reflecting a complex interplay of directional bets and volatility in the stock." }, { "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-volatile-trading-4130268", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_oi_spurts_by_underlying_4130268.png", "date": "2026-07-31 11:00:12", "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline and increased volatility, the pharmaceutical company’s futures and options contracts have attracted substantial volume, reflecting evolving directional bets and strategic plays by market participants." }, { "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-volatile-trading-4129863", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_oi_spurts_by_underlying_4129863.png", "date": "2026-07-31 10:00:07", "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the pharmaceutical company’s futures and options contracts have seen a 16.8% increase in open interest, reflecting growing speculative interest and potential directional bets amid volatile trading conditions." } ], "total": 581, "sid": "1003845", "stock_news_url": "https://www.marketsmojo.com/news/mankind-pharma-1003845" }, "announcements": [ { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "06-Aug-2026", "details": "Please find attached Voting Results and Scrutinizers Report of 35th AGM", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM", "datetime": "04-Aug-2026", "details": "Please find attached proceedings of the 35th AGM of the Company", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "04-Aug-2026", "details": "Please find attached transcript of the Investor Conference call for Q1FY27 held on July 30 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Mankind Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Aug 25", "dt": "2025-08-08", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Jul: Stock rises 1.82% amid broad market gains

28 Jul: Sharp open interest surge of 14.5% despite Sensex dip

29 Jul: Open interest climbs 15.2%, Mojo Grade upgraded to Buy

30 Jul: Q1 FY27 results reveal strong revenue growth but margin pressures

31 Jul: Intraday low hit at Rs.2,445.45 amid heavy selling and 45.8% open interest surge

Week Open

Read full news article

Are Mankind Pharma Ltd latest results good or bad?

2026-07-31 19:22:27

Mankind Pharma Ltd's latest financial results for the quarter ended June 2026 present a complex picture characterized by strong revenue growth alongside margin pressures. The company reported net sales of ₹4,030.59 crores, reflecting a sequential increase of 17.07% from the previous quarter, which marks the highest quarterly revenue in its history. Year-on-year, sales also showed a healthy growth of 12.89%, indicating robust demand across its product portfolio and effective market strategies. However, the net profit for the same quarter was ₹568.06 crores, which represents a modest sequential growth of 2.47%. This contrasts with the more substantial profit growth seen in the previous quarter. The operating margin decreased to 26.20%, down 81 basis points from the prior quarter, highlighting the impact of rising employee costs, which surged by 21.54% sequentially. This increase in employee expenses has rais...

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading

2026-07-31 15:00:23

Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the pharmaceutical company’s futures and options contracts have attracted increased volumes, reflecting a complex interplay of directional bets and volatility.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading

2026-07-31 14:00:17

Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market reveals intriguing directional bets that merit close attention from investors and analysts alike.

Read full news article

Mankind Pharma Ltd Sees Sharp Open Interest Surge Amid Volatile Trading

2026-07-31 13:00:14

Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market shows signs of increased speculative interest, raising questions about potential directional bets and future price movements.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading

2026-07-31 12:00:14

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading

2026-07-31 11:00:12

Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline and increased volatility, the pharmaceutical company’s futures and options contracts have attracted substantial volume, reflecting evolving directional bets and strategic plays by market participants.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading

2026-07-31 10:00:07

Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the pharmaceutical company’s futures and options contracts have seen a 16.8% increase in open interest, reflecting growing speculative interest and potential directional bets amid volatile trading conditions.

Read full news article